Clinipace
Morrisville, US · Delaware corporation · 3 known investors
Caidya is a contract research organization (CRO) that provides scientific, medical, and operational support for clinical development and cross-border clinical trials. It focuses on managing complex trials and delivering clinical data to support decision-making for drug developers.
Founders & leadership
MU
Mark UbertExecutive
JW
Jesse WatsonNamed on SEC filing
BC
Brian CarneyNamed on SEC filing
JL
Jeff L. WilliamsNamed on SEC filing
MD
Melissa DanielsNamed on SEC filing
CK
Christopher K. PorterNamed on SEC filing
JM
Jeremy MarioNamed on SEC filing
GR
Gena ReedNamed on SEC filing
DF
David FitzgeraldNamed on SEC filing
Board
KL
Ken LeeBoard director
JC
John CrumplerBoard director
JG
Julia GregoryBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$76.2M disclosed across 12 rounds · 2014–2020
▶$4.1MraisedOct 2020 · 10 investors · Other Health CareRule 506(b)
▶$4.1MraisedOct 2020 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Melissa DanielsDirector
- Jeremy MarioDirector
- David FitzgeraldDirector
- Jesse WatsonDirector
- Steve SkolskyDirector
- Steven ListDirector
- Jason MonteleoneExecutive Officer, Director
- Offering amount
- $10M
- Amount sold
- $4.1M
- First sale
- Sep 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$14.7MraisedFeb 2020 · 16 investors · Other Health CareRule 506(b)
▶$14.7MraisedFeb 2020 · 16 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jeremy MarioDirector
- Jason MonteleoneExecutive Officer, Director
- Melissa DanielsDirector
- Chris SempleDirector
- David FitzgeraldDirector
- Jesse WatsonDirector
- Steve SkolskyDirector
- Offering amount
- $14.7M
- Amount sold
- $14.7M
- First sale
- Oct 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.8MraisedAug 2019 · 13 investors · Other Health CareRule 506(b)
▶$3.8MraisedAug 2019 · 13 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Chris SempleDirector
- Jesse WatsonDirector
- Steve SkolskyDirector
- Jason MonteleoneExecutive Officer, Director
- Melissa DanielsDirector
- Jeremy MarioDirector
- David FitzgeraldDirector
- Offering amount
- $3.8M
- Amount sold
- $3.8M
- First sale
- Jul 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4MraisedMar 2019 · 13 investors · Other Health CareRule 506(b)
▶$4MraisedMar 2019 · 13 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jesse WatsonDirector
- David FitzgeraldDirector
- Steve SkolskyDirector
- Jason MonteleoneExecutive Officer, Director
- Melissa DanielsDirector
- Jeremy MarioDirector
- Chris SempleDirector
- Offering amount
- $4M
- Amount sold
- $4M
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.7MraisedSep 2018 · 13 investors · Other Health CareRule 506(b)
▶$5.7MraisedSep 2018 · 13 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jason MonteleoneExecutive Officer, Director
- Jeremy MarioDirector
- Jesse WatsonDirector
- David FitzgeraldDirector
- Steve SkolskyDirector
- Melissa DanielsDirector
- Chris SempleDirector
- Offering amount
- $5.7M
- Amount sold
- $5.7M
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10MraisedDec 2017 · 16 investors · Other Health CareRule 506(b)
▶$10MraisedDec 2017 · 16 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jeremy MarioDirector
- Jason MonteleoneExecutive Officer, Director
- Steve SkolskyDirector
- Jesse WatsonDirector
- David FitzgeraldDirector
- Melissa DanielsDirector
- Chris SempleDirector
- Offering amount
- $20M
- Amount sold
- $10M
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3MraisedNov 2017 · 13 investors · Other Health CareRule 506(b)
▶$3MraisedNov 2017 · 13 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jeff WilliamsDirector
- Melissa DanielsDirector
- Jeremy MarioDirector
- Gena ReedDirector
- Ken LeeDirector
- Jason MonteleoneExecutive Officer
- David FitzgeraldDirector
- Steve SkolskyDirector
- Jesse WatsonDirector
- Brian CarneyDirector
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Nov 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.7MraisedJul 2016 · 10 investors · Other Health CareRule 506(b)
▶$3.7MraisedJul 2016 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mark UbertExecutive Officer
- Ken LeeDirector
- Jesse WatsonDirector
- Brian CarneyDirector
- Jeff L. WilliamsExecutive Officer, Director
- Melissa DanielsDirector
- Christopher K. PorterExecutive Officer
- Jeremy MarioDirector
- Gena ReedDirector
- David FitzgeraldDirector
- Offering amount
- $4.3M
- Amount sold
- $3.7M
- First sale
- Jul 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Clinipace do?
- Caidya is a contract research organization (CRO) that provides scientific, medical, and operational support for clinical development and cross-border clinical trials. It focuses on managing complex trials and delivering clinical data to support decision-making for drug developers.
- Who are Clinipace's investors?
- Clinipace's investors include Creathor Ventures, Hatteras Venture Partners, OUP (Osage University Partners).
- How much funding has Clinipace raised?
- Clinipace has disclosed $76.2M raised across 12 rounds.
- Where is Clinipace headquartered?
- Clinipace is headquartered in Morrisville, US.